Clinical studies on Cu-7; copper-IUD
- PMID: 12158549
Clinical studies on Cu-7; copper-IUD
Abstract
PIP: The effectivenss and acceptability of the Copper-7 (Cu-7) IUD was assessed over a total of 8064.5 woman-months calculated by the life-table method of Tietze-Lewit, were accidental pregnancy, 3.1; spontaneous expulsion, 3.2; removal for bleeding and/or pain, 3.7; removal for other medical reasons, .5; removal for planned pregnancy, 5.3; and removal for other personal reasons, 5.2. The overall termination rate was 21/100 women. Most of the side effects occurred within the first 6 months of use. There were no cases of pelvic infection. The incidence of side effects and the reversibility of the method did not appear to be affected by the addition of copper to the device. Serum progesterone, estrogen, copper, and iron levels remained within the normal range. No marked endometritis was observed. It is concluded that the CU-7 IUD is a safe and effective contraceptive device.
Similar articles
-
[Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].Patol Clin Ostet Ginecol. 1985 Jan-Feb;13(1):49-56. Patol Clin Ostet Ginecol. 1985. PMID: 12342024 Italian.
-
[The effect of intrauterine contraceptive devices on the endometrium].Contracept Fertil Sex (Paris). 1987 Nov;15(11):1015-24. Contracept Fertil Sex (Paris). 1987. PMID: 12341565 French.
-
Continuing IUD research.Netw Res Triangle Park N C. 1981 Jan;2(2):4. Netw Res Triangle Park N C. 1981. PMID: 12339100
-
[A fundamental study of Copper-T (intrauterine device). Part 1 (author's transl)].Nihon Funin Gakkai Zasshi. 1978 Jan;23(1):28-35. Nihon Funin Gakkai Zasshi. 1978. PMID: 12158555 Japanese.
-
Gestational diabetes in the past: a relative contraindication for intrauterine contraception.Adv Contracept Deliv Syst. 1985;(1):131-2. Adv Contracept Deliv Syst. 1985. PMID: 12267109